Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Last trade$158.42
Day change-$0.97 (-0.61%)
Day range$157.69 – $165.43
Volume215,693
Market cap$12.02B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$12.02B
Price / earnings
9.92×
Price / book
1.95×
Price / sales
1.94×
EV / sales
2.38×
EV / EBITDA
7.06×
Profitability
Earnings per share
$16.07
Return on assets
3.84%
Return on equity
19.69%
Dividend yield
0.75%
Liquidity and leverage
Debt / equity
0.48×
Current ratio
3.81×
Quick ratio
3.81×
Cash ratio
0.91×
Cash flow
Price / cash flow
8.64×
Price / free cash flow
9.76×
Free cash flow
$1.23B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for GL, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$1.6B
$1.56B
$1.52B
$1.51B
$1.48B
$1.48B
$1.47B
$1.46B
Cost of revenue
$918.79M
$907.87M
$877.68M
$730.7M
$867.4M
$856.28M
$843.07M
$792.49M
Gross profit
$680.94M
$651.75M
$641.94M
$782.29M
$613.89M
$624.14M
$623.21M
$662.91M
Selling, general and administrative
$0
$0
$0
$0
$0
$0
$0
$0
Research and development
—
—
—
—
—
—
—
—
Total operating expenses
$1.21B
$1.19B
$1.15B
$999.75M
$1.13B
$1.13B
$1.12B
$1.05B
Operating income
$390.94M
$368.13M
$364.7M
$513.24M
$348.18M
$351.07M
$348.11M
$408.35M
Interest expense
-$36.05M
-$34M
-$35.21M
-$36.13M
-$34.89M
-$34.99M
-$35.68M
-$31.39M
Income before taxes
$354.89M
$334.13M
$329.49M
$477.1M
$313.3M
$316.08M
$312.43M
$376.96M
Income taxes
$67.14M
$63.61M
$63.41M
$89.26M
$60.55M
$61.52M
$57.24M
$73.96M
Net income
$287.75M
$270.53M
$266.08M
$387.84M
$252.75M
$254.56M
$255.2M
$302.99M
Net income attributable to common shareholders
$287.75M
$270.53M
$266.08M
$387.84M
$252.75M
$254.56M
$255.2M
$302.99M
EBITDA
$390.94M
$368.13M
$812.46M
$513.24M
$348.18M
$351.07M
$758.11M
$408.35M
Basic earnings per share
$3.71
$3.45
$3.35
$4.81
$3.09
$3.05
$3.04
$3.45
Diluted earnings per share
$3.65
$3.39
$3.29
$4.73
$3.05
$3.01
$3.04
$3.44
Recent news
Company coverage with links to the original publishers.
Globe Life Inc. (GL) has rallied 22.3% over the past year, outperforming the insurance industry. The company expects 6-8% premium growth in 2027 supported by health insurance revenues, AI adoption, and distribution expansion. GL trades at a forward P/E of 9.88, below the industry average of 13.56, with analysts setting an average price target of $186.15, implying 15.8% upside. However, risks include vulnerable middle-income customer base, agent recruitment challenges, and health underwriting volatility.
The Accident & Health Insurance industry faces pricing pressures and rising medical costs, but benefits from increased demand for supplemental health products and technology adoption. Five insurers—Aflac, Unum Group, Globe Life, Trupanion, and Employers Holdings—are highlighted as potential investments despite industry headwinds. The industry carries a Zacks Industry Rank #196 (bottom 21%), though it has outperformed the broader market year-to-date.
The Accident and Health Insurance industry faces pricing pressures and medical inflation challenges, but benefits from growing demand for supplemental health insurance and technology adoption. Despite outperforming the S&P 500 year-to-date with a 12.2% gain, the industry carries a weak Zacks Industry Rank #196, reflecting negative earnings outlooks. Five stocks are highlighted as potential holdings with mixed growth prospects.
Globe Life reported Q3 2026 operating EPS of $4.84, slightly missing estimates but growing 0.6% year-over-year. Premium revenues rose 6.5%, but underwriting income fell 4.2% and expenses surged 11.5%, pressuring profitability. The company revised its 2026 EPS guidance downward to $15.35-$15.65 due to adverse results at United American, while raising share repurchase forecasts. Book value per share increased 22.8% year-over-year.
Globe Life reported Q3 2026 revenue of $1.61 billion, up 5.9% year-over-year, slightly missing consensus estimates by 0.03%. EPS of $4.84 fell short of the $4.87 estimate by 0.62%. While total premiums and net investment income met expectations, several underwriting margins underperformed, particularly Liberty National and Other segments which declined significantly. The stock holds a Zacks Rank #3 (Hold) rating.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.33 per share
Declared
Nov 5, 2026
Ex-dividend
Jan 8, 2027
Pay date
Feb 1, 2027
Ex-dividend
Amount / share
Pay date
Type
Oct 5, 2026
$0.33
Oct 30, 2026
recurring
Jul 6, 2026
$0.33
Jul 31, 2026
recurring
Apr 2, 2026
$0.33
May 1, 2026
recurring
Jan 5, 2026
$0.27
Jan 30, 2026
recurring
Oct 3, 2025
$0.27
Oct 31, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.